Neovasc Inc.
NVCN
NVCN was delisted on the 10th of April, 2023.
11 hedge funds and large institutions have $1.72M invested in Neovasc Inc. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
462% more capital invested
Capital invested by funds: $305K → $1.72M (+$1.41M)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$409K |
| 2 |
CL
Choreo LLC
Rockford,
Illinois
|
+$102K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.16K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.76K |
| 2 |
JP Morgan Chase
New York
|
-$2.46K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.64K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
NVCN Hedge Fund Activity: Q4 2022 in Review
11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Neovasc Inc. (NVCN) for Q4 2022, worth a combined $1.72M — up 462% from $305K a quarter earlier.
Fund positioning in NVCN was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Natixis, opening a new position worth an estimated $409K. The largest seller was Morgan Stanley, cutting an estimated $7.76K.
- 11 institutional investors held Neovasc Inc. (NVCN) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $1.72M of Neovasc Inc. stock for Q4 2022, up 462% quarter-over-quarter.
- 2 funds opened new Neovasc Inc. positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Neovasc Inc. buyer in Q4 2022 was Natixis, an estimated $409K added.
- The largest Neovasc Inc. seller in Q4 2022 was Morgan Stanley, an estimated $7.76K sold.
Based on aggregated 13F filings for Q4 2022.